Hamps Bio Ltd — Board Meeting, 28-05-2025: Board Meeting

Hamps Bio Ltd. has announced a board meeting on which approved the audited standalone financial results for the quarter and half-year ended March 31, 2025, with an unmodified auditor’s opinion from MGVS & Associates. Revenue stood at Rs. 666.87 lakhs, up from Rs. 647.52 lakhs last year, while profit after tax rose to Rs. 29.77 lakhs versus Rs. 50.06 lakhs previously. The company appointed Richa Goyal & Associates as Secretarial Auditor for five years, subject to shareholder approval, and appointed Naviwala & Associates as Internal Auditor for FY 2025-26. Capital expenditure includes plant and machinery additions and solar energy systems, with related borrowing costs capitalized as qualifying assets. Proceeds from the IPO have been partly utilized, with the balance invested in fixed deposits.